kongre.net
Welcome to kongre.net

Speaker

Jesse Chen

President & Chief Executive Officer, Fortitude Biomedicines

Jesse Chen, President & Chief Executive Officer at Fortitude Biomedicines, spoke at Oncology & Immunology Innovation Partnering & Licensing Summit (Boston, United States of America, 9–10 Sept 2026) in the session “Increasing the Therapeutic Index of a Small Molecule as Precision ADCs: What Have we Learnt so Far?”.

Conferences
1
Keynotes
0
Upcoming
0

Past appearances

More speakers at Oncology & Immunology Innovation Partnering & Licensing Summit

  • Carla Bauer

    Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co

  • Akihiro Furukawa

    Global Director, Research & Technology Search & Evaluation, Daiichi Sankyo

  • Adam Gilbert

    Science Partner, Flagship Pioneering

  • Mike Jones

    Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical

  • Nikhil Mutyal

    Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca

  • Giovanni Spagnolli

    Co-Founder & Chief Technology Officer, Sibylla Biotech srl

See all 55 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Jesse Chen, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].